Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1985-11-12
1986-10-07
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514913, A61K 3154
Patent
active
046160124
ABSTRACT:
Methods and pharmaceutical compositions are disclosed for reducing intraocular pressure. The methods and compositions employ an active ingredient which comprises certain benzothiadiazinyl and quinazolinyl substituted carboxyalkyl dipeptides wherein the benzothiadiazinyl or quinazolinyl portions are joined to the dipeptide portions by an aminocarbonyl group.
REFERENCES:
patent: 4338435 (1982-07-01), Haugwitz
patent: 4376768 (1983-03-01), Ozaki et al.
patent: 4431645 (1984-02-01), Smith et al.
patent: 4468396 (1984-08-01), Magatti
patent: 4551452 (1985-11-01), Marfat
Abstract of European Patent Application 95584--Dec. 1983.
Abstract of Australian Patent Application 8,313,837, Nov. 1983.
Andrews David R.
McNamara Paul E.
Neustadt Bernard R.
Watkins Robert W.
Magatti Anita W.
Miller Stephen I.
Nelson James R.
Robinson Douglas W.
Schering Corporation
LandOfFree
Carboxyalkyl dipeptides as antiglaucoma agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Carboxyalkyl dipeptides as antiglaucoma agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Carboxyalkyl dipeptides as antiglaucoma agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-643405